- Marketwired•5 hours ago
Prima BioMed Ltd announces the granting of patent number 2142210 entitled "Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune ...
- Marketwired•7 days ago
Prima BioMed Ltd , has provided an update on the Company's cash position and the recruitment progress in its two active clinical trials in IMP321.
- Marketwired•15 days ago
Prima BioMed Ltd , has received notification from the Listing Qualifications Department of The NASDAQ Stock Market indicating that, for the period from June 24, 2016 through August 5, 2016, the closing ...
Prima Biomed Ltd. (PRR.AX)
ASX - ASX Delayed Price. Currency in AUD
|Day's Range||0.04 - 0.04|
|52wk Range||0.04 - 0.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.93|
|Avg Vol (3m)||1,465,976|
|Dividend & Yield||N/A (N/A)|